Pilot Trial Evaluating Viral Protein Production From the Combination of Reolysin and Carfilzomib in Multiple Myeloma
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Pelareorep (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 21 Apr 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2018.
- 21 Apr 2017 Status changed from suspended to recruiting.
- 03 Jul 2016 Planned number of patients changed from 12 to 28.